Feasibility of Home Parenteral Nutrition in Patients with Intestinal Failure Due to Neuroendocrine Tumours: A Systematic Review
Authors:
- Dominique S. V. M. ClementDCDominique S. V. M. Clement
- Sarah E. BrownSBSarah E. Brown
- Mani NaghibiMNMani Naghibi
- Sheldon C. CooperSCSheldon C. Cooper
- Margot E. T. TesselaarMTMargot E. T. Tesselaar
- Monique E. van LeerdamMLMonique E. van Leerdam
- John K. RamageJRJohn K. Ramage
- Rajaventhan SrirajaskanthanRSRajaventhan Srirajaskanthan
Open Access
Abstract
Introduction: Maintaining adequate nutritional status can be a challenge for patients with small bowel neuroendocrine tumours (NETs). Surgical resection could result in short bowel syndrome (SBS), whilst without surgical resection there is a considerable risk of ischemia or developing an inoperable malignant bowel obstruction (IMBO). SBS or IMBO are forms of intestinal failure (IF) which might require treatment with home parenteral nutrition (HPN). Limited data exist regarding the use of HPN in patients with small bowel neuroendocrine tumours, and it is not frequently considered as a possible treatment. Methods: A systematic review was performed regarding patients with small bowel NETs and IF to report on overall survival and HPN-related complications and create awareness for this treatment. Results: Five articles regarding patients with small bowel NETs or a subgroup of patients with NETs could be identified, mainly case series with major concerns regarding bias. The studies included 60 patients (range 1–41). The overall survival time varied between 0.5 and 154 months on HPN. However, 58% of patients were alive 1 year after commencing HPN. The reported catheter-related bloodstream infection rate was 0.64–2 per 1000 catheter days. Conclusion: This systematic review demonstrates the feasibility of the use of HPN in patients with NETs and IF in expert centres with a reasonable 1-year survival rate and low complication rate. Further research is necessary to compare patients with NETs and IF with and without HPN and the effect of HPN on their quality of life.Keywords
This publication has 47 references indexed in Scilit:
- Current state of knowledge on neuroendocrine small bowel tumours: non-systematic review of the literature based on one caseBMJ Case Reports, 2013
- Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2012
- Neuroendocrine tumors of midgut and hindgut origin: Tumor‐node‐metastasis classification determines clinical outcomeCancer, 2011
- An Exploration of Quality of Life and the Experience of Living With Home Parenteral NutritionJournal of Parenteral and Enteral Nutrition, 2010
- The Clinical and Psychometric Validation of a Questionnaire to Assess the Quality of Life of Adult Patients Treated With Long‐Term Parenteral NutritionJournal of Parenteral and Enteral Nutrition, 2009
- Eating habits and quality of life of patients receiving home parenteral nutrition in IsraelClinical Nutrition, 2008
- Nutritional intervention and quality of life in adult oncology patientsClinical Nutrition, 2007
- Survival and dependence on home parenteral nutrition: experience over a 25‐year period in a UK referral centreAlimentary Pharmacology & Therapeutics, 2006
- Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition?Cancer, 2005
- Quality of Life in Patients on Permanent Home Parenteral NutritionJournal of Parenteral and Enteral Nutrition, 1981